vs
MAXIMUS, INC.（MMS）とTapestry, Inc.（TPR）の財務データ比較。上の社名をクリックして会社を切り替えられます
Tapestry, Inc.の直近四半期売上が大きい（$2.5B vs $1.3B、MAXIMUS, INC.の約1.9倍）。Tapestry, Inc.の純利益率が高く（22.4% vs 7.0%、差は15.4%）。Tapestry, Inc.の前年同期比売上増加率が高い（14.0% vs -4.1%）。Tapestry, Inc.の直近四半期フリーキャッシュフローが多い（$1.0B vs $-250.7M）。過去8四半期でTapestry, Inc.の売上複合成長率が高い（29.9% vs -0.1%）
MAXIMUS社は米国の政府向けサービス企業で、米国、カナダ、英国などで事業を展開している。メディケイド、メディケア、医療改革、就労支援、学生ローン管理など各種政府プログラムに管理業務や関連サービスを提供する。本社はバージニア州タイソンズに所在し、従業員数3万9600人、2024会計年度の売上高は53億米ドルである。
Tapestry, Inc.はアメリカ発の大手多国籍ラグジュアリーファッション持株会社で、Coach、Kate Spade New York、Stuart Weitzmanの3つの代表的なライフスタイルブランドを保有し、高級ハンドバッグ、アパレル、靴、アクセサリー、香水などを世界中の消費者に提供しています。
MMS vs TPR — 直接比較
損益計算書 — Q1 FY2026 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.3B | $2.5B |
| 純利益 | $93.9M | $561.3M |
| 粗利率 | 23.7% | 75.5% |
| 営業利益率 | 10.9% | 28.6% |
| 純利益率 | 7.0% | 22.4% |
| 売上前年比 | -4.1% | 14.0% |
| 純利益前年比 | 128.0% | 80.8% |
| EPS（希薄化後） | $1.70 | $2.68 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.3B | $2.5B | ||
| Q3 25 | $1.3B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.5B |
| Q4 25 | $93.9M | $561.3M | ||
| Q3 25 | $75.3M | $274.8M | ||
| Q2 25 | $106.0M | $-517.1M | ||
| Q1 25 | $96.6M | $203.3M | ||
| Q4 24 | $41.2M | $310.4M | ||
| Q3 24 | $72.5M | $186.6M | ||
| Q2 24 | $89.8M | $159.3M | ||
| Q1 24 | $80.5M | $139.4M |
| Q4 25 | 23.7% | 75.5% | ||
| Q3 25 | 25.3% | 76.3% | ||
| Q2 25 | 26.7% | 76.3% | ||
| Q1 25 | 24.9% | 76.1% | ||
| Q4 24 | 21.5% | 74.4% | ||
| Q3 24 | 22.9% | 75.3% | ||
| Q2 24 | 25.3% | 74.9% | ||
| Q1 24 | 23.6% | 74.7% |
| Q4 25 | 10.9% | 28.6% | ||
| Q3 25 | 9.3% | 19.3% | ||
| Q2 25 | 12.3% | -33.9% | ||
| Q1 25 | 11.2% | 16.0% | ||
| Q4 24 | 6.2% | 22.4% | ||
| Q3 24 | 8.5% | 16.7% | ||
| Q2 24 | 10.8% | 14.8% | ||
| Q1 24 | 9.5% | 13.8% |
| Q4 25 | 7.0% | 22.4% | ||
| Q3 25 | 5.7% | 16.1% | ||
| Q2 25 | 7.9% | -30.0% | ||
| Q1 25 | 7.1% | 12.8% | ||
| Q4 24 | 2.9% | 14.1% | ||
| Q3 24 | 5.5% | 12.4% | ||
| Q2 24 | 6.8% | 10.0% | ||
| Q1 24 | 6.0% | 9.4% |
| Q4 25 | $1.70 | $2.68 | ||
| Q3 25 | $1.27 | $1.28 | ||
| Q2 25 | $1.86 | $-2.30 | ||
| Q1 25 | $1.69 | $0.95 | ||
| Q4 24 | $0.69 | $1.38 | ||
| Q3 24 | $1.18 | $0.79 | ||
| Q2 24 | $1.46 | $0.67 | ||
| Q1 24 | $1.31 | $0.60 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $137.6M | $1.1B |
| 総負債低いほど良い | — | $2.4B |
| 株主資本純資産 | $1.7B | $551.2M |
| 総資産 | $4.2B | $6.5B |
| 負債/資本比率低いほどレバレッジが低い | — | 4.32× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $137.6M | $1.1B | ||
| Q3 25 | $222.4M | $743.2M | ||
| Q2 25 | $59.8M | $1.1B | ||
| Q1 25 | $108.1M | $1.1B | ||
| Q4 24 | $72.7M | $1.0B | ||
| Q3 24 | $183.1M | $7.3B | ||
| Q2 24 | $102.8M | $7.2B | ||
| Q1 24 | $77.4M | $7.4B |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $7.0B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $7.7B |
| Q4 25 | $1.7B | $551.2M | ||
| Q3 25 | $1.7B | $399.5M | ||
| Q2 25 | $1.8B | $857.8M | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.8B | $3.0B | ||
| Q2 24 | $1.8B | $2.9B | ||
| Q1 24 | $1.8B | $2.8B |
| Q4 25 | $4.2B | $6.5B | ||
| Q3 25 | $4.1B | $6.4B | ||
| Q2 25 | $4.5B | $6.6B | ||
| Q1 25 | $4.2B | $7.3B | ||
| Q4 24 | $4.1B | $7.3B | ||
| Q3 24 | $4.1B | $13.7B | ||
| Q2 24 | $4.0B | $13.4B | ||
| Q1 24 | $4.0B | $13.7B |
| Q4 25 | — | 4.32× | ||
| Q3 25 | — | 5.95× | ||
| Q2 25 | — | 2.77× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 2.35× | ||
| Q2 24 | — | 2.39× | ||
| Q1 24 | — | 2.77× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-244.4M | $1.1B |
| フリーキャッシュフロー営業CF - 設備投資 | $-250.7M | $1.0B |
| FCFマージンFCF / 売上 | -18.6% | 41.5% |
| 設備投資強度設備投資 / 売上 | 0.5% | 1.7% |
| キャッシュ転換率営業CF / 純利益 | -2.60× | 1.93× |
| 直近12ヶ月FCF直近4四半期 | $218.5M | $1.6B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-244.4M | $1.1B | ||
| Q3 25 | $649.4M | $112.6M | ||
| Q2 25 | $-182.7M | $446.8M | ||
| Q1 25 | $42.7M | $144.3M | ||
| Q4 24 | $-80.0M | $506.0M | ||
| Q3 24 | $163.8M | $119.5M | ||
| Q2 24 | $199.3M | $256.0M | ||
| Q1 24 | $130.5M | $97.8M |
| Q4 25 | $-250.7M | $1.0B | ||
| Q3 25 | $641.8M | $80.2M | ||
| Q2 25 | $-198.2M | $411.5M | ||
| Q1 25 | $25.5M | $113.4M | ||
| Q4 24 | $-103.0M | $475.1M | ||
| Q3 24 | $131.9M | $93.9M | ||
| Q2 24 | $164.6M | $209.8M | ||
| Q1 24 | $105.2M | $78.8M |
| Q4 25 | -18.6% | 41.5% | ||
| Q3 25 | 48.7% | 4.7% | ||
| Q2 25 | -14.7% | 23.9% | ||
| Q1 25 | 1.9% | 7.2% | ||
| Q4 24 | -7.3% | 21.6% | ||
| Q3 24 | 10.0% | 6.2% | ||
| Q2 24 | 12.5% | 13.2% | ||
| Q1 24 | 7.8% | 5.3% |
| Q4 25 | 0.5% | 1.7% | ||
| Q3 25 | 0.6% | 1.9% | ||
| Q2 25 | 1.1% | 2.0% | ||
| Q1 25 | 1.3% | 2.0% | ||
| Q4 24 | 1.6% | 1.4% | ||
| Q3 24 | 2.4% | 1.7% | ||
| Q2 24 | 2.6% | 2.9% | ||
| Q1 24 | 1.9% | 1.3% |
| Q4 25 | -2.60× | 1.93× | ||
| Q3 25 | 8.63× | 0.41× | ||
| Q2 25 | -1.72× | — | ||
| Q1 25 | 0.44× | 0.71× | ||
| Q4 24 | -1.94× | 1.63× | ||
| Q3 24 | 2.26× | 0.64× | ||
| Q2 24 | 2.22× | 1.61× | ||
| Q1 24 | 1.62× | 0.70× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
TPR
| Coach | $1.4B | 57% |
| Other | $787.0M | 31% |
| Kate Spade Company | $290.0M | 12% |
